These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 7845018)

  • 1. Expression of the Evi-1 gene in myelodysplastic syndromes.
    Dreyfus F; Bouscary D; Melle J; Ribrag V; Guesnu M; Varet B
    Leukemia; 1995 Jan; 9(1):203-5. PubMed ID: 7845018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evi-1 and MDS1-Evi-1 genes in pathogenesis of myelodysplastic syndromes and post-MDS acute myeloid leukemia.
    Xu K; Wang L; Hao Y; Shao Z; Meng Q; Li K; Chao H; Tang K; Wang L
    Chin Med J (Engl); 1999 Dec; 112(12):1112-8. PubMed ID: 11721451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EVI1 Impairs myelopoiesis by deregulation of PU.1 function.
    Laricchia-Robbio L; Premanand K; Rinaldi CR; Nucifora G
    Cancer Res; 2009 Feb; 69(4):1633-42. PubMed ID: 19208846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro stimulation of erythropoiesis by stem cell factor alone in myelodysplastic syndrome patients with elevated endogenous erythropoietin serum levels.
    Zwierzina H; Bammer T; Rollinger-Holzinger I; Herold M; Fenaux P; Nüssler V; Hoflehner E; Geissler D
    Clin Cancer Res; 1996 Jun; 2(6):1031-8. PubMed ID: 9816264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Alteration of methylation status of fragile histidine triad gene promoter in patients with myelodysplastic syndrome].
    Yao DM; Qian J; Xu WR; Lin J; Jiang YW; Fei X; Han LX; Wang Y; Cen JN; Chen ZX
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Feb; 25(1):36-9. PubMed ID: 18247301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of erythropoietin responsiveness in erythroid progenitors due to expression of the Evi-1 myeloid-transforming gene.
    Kreider BL; Orkin SH; Ihle JN
    Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6454-8. PubMed ID: 8341654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in the ras proto-oncogenes in patients with myelodysplastic syndromes.
    Neubauer A; Greenberg P; Negrin R; Ginzton N; Liu E
    Leukemia; 1994 Apr; 8(4):638-41. PubMed ID: 7512175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased Evi-1 expression is frequently observed in blastic crisis of chronic myelocytic leukemia.
    Ogawa S; Kurokawa M; Tanaka T; Tanaka K; Hangaishi A; Mitani K; Kamada N; Yazaki Y; Hirai H
    Leukemia; 1996 May; 10(5):788-94. PubMed ID: 8656673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of APAF-1 in low-risk myelodysplastic syndrome: a possible role in the pathophysiology of myelodysplasia.
    Benites BD; Traina F; Duarte Ada S; Lorand-Metze IG; Costa FF; Saad ST
    Eur J Haematol; 2010 Jun; 84(6):525-30. PubMed ID: 20345447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study on expression of Evi1 and MDS1-Evi1 genes in myelodysplastic syndromes].
    Xu K; Wang L; Hao Y
    Zhonghua Xue Ye Xue Za Zhi; 1998 Jun; 19(6):315-9. PubMed ID: 11243114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythropoiesis in myelodysplastic syndrome: expression of receptors for erythropoietin and kit ligand.
    Backx B; Broeders L; Hoefsloot LH; Wognum B; Löwenberg B
    Leukemia; 1996 Mar; 10(3):466-72. PubMed ID: 8642863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and regulation of the evi-1 gene in the human factor-dependent leukemia cell line, UCSD/AML1.
    Oval J; Smedsrud M; Taetle R
    Leukemia; 1992 May; 6(5):446-51. PubMed ID: 1593910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome.
    Rosati S; Mick R; Xu F; Stonys E; Le Beau MM; Larson R; Vardiman JW
    Leukemia; 1996 Jan; 10(1):20-6. PubMed ID: 8558932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of c-mpl expression in myelodysplastic syndromes.
    Bouscary D; Preudhomme C; Ribrag V; Melle J; Viguié F; Picard F; Guesnu M; Fenaux P; Gisselbrecht S; Dreyfus F
    Leukemia; 1995 May; 9(5):783-8. PubMed ID: 7539513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of stem-cell factor, interleukin-3 and erythropoietin on in vitro erythropoiesis in myelodysplastic syndromes.
    Verbeek W; Vehmeyer K; Wörmann B; Hiddemann W
    J Cancer Res Clin Oncol; 1995; 121(6):338-42. PubMed ID: 7797598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of thrombopoietin on proliferation of blasts from patients with myelodysplastic syndromes.
    Luo SS; Ogata K; Yokose N; Kato T; Dan K
    Stem Cells; 2000; 18(2):112-9. PubMed ID: 10742383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic dysregulation of GATA1 is involved in myelodysplastic syndromes dyserythropoiesis.
    Hopfer O; Nolte F; Mossner M; Komor M; Kmetsch A; Benslasfer O; Reissmann M; Nowak D; Hoelzer D; Thiel E; Hofmann WK
    Eur J Haematol; 2012 Feb; 88(2):144-53. PubMed ID: 21967505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophil-specific reduction in the expression of granulocyte--macrophage colony-stimulating factor receptor subunits in myelodysplastic syndromes.
    Shikama Y; Shichishima T; Ohto H; Jubinsky PT; Maruyama Y
    Br J Haematol; 2000 Dec; 111(3):863-72. PubMed ID: 11122148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth analysis of marrow CD34-positive hematopoietic progenitor cells in patients with myelodysplastic syndromes.
    Asano H; Hotta T; Ichihara M; Murate T; Kobayashi M; Saito H
    Leukemia; 1994 May; 8(5):833-8. PubMed ID: 7514249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transformation of myelodysplastic syndromes into acute myeloid leukemias.
    Shi J; Shao ZH; Liu H; Bai J; Cao YR; He GS; Tu MF; Wang XL; Hao YS; Yang TY; Yang CL
    Chin Med J (Engl); 2004 Jul; 117(7):963-7. PubMed ID: 15265365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.